Galecto Inc

Discover how Copenhagen‑based Galecto, Inc. is pioneering small‑molecule drugs to fight fibrosis, cancer, and inflammation, and what this means for investors and patients.

Galecto Inc, a clinical-stage biotech company, is pioneering the development of small molecules to treat severe diseases, positioning itself as a leader in the fight against fibrosis, cancer, and inflammation.